Aspirin and P2Y12 inhibitors in treating COVID-19

被引：2
|
作者：
Khalaji, Amirmohammad [1 ]
Behnoush, Amir Hossein [1 ]
Peiman, Soheil [2 ,3 ]
机构：
[1] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[2] AdventHlth Orlando Hosp, Dept Internal Med, Orlando, FL USA
[3] AdventHlth Orlando Hosp, Dept Internal Med, 601 E Rollins St Suite 400, Orlando, FL 32803 USA
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 110卷
关键词：
COVID-19; Aspirin; P2Y12; inhibitors; Platelet aggregation inhibitors; Meta-analysis;
D O I：
10.1016/j.ejim.2022.11.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 50 条
  • [21] Optimizing Monotherapy Selection, Aspirin Versus P2Y12 Inhibitors, Following Percutaneous Coronary Intervention
    Yerasi, Charan
    Case, Brian C.
    Forrestal, Brian J.
    Torguson, Rebecca
    Weintraub, William S.
    Garcia-Garcia, Hector M.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 135 : 154 - 165
  • [22] What is the best dose of aspirin in association with P2Y12 antagonists?
    Cattaneo, Marco
    HEART, 2011, 97 (03) : 263 - 264
  • [23] Thrombus remodelling by reversible and irreversible P2Y12 inhibitors
    Tunstromer, Kjersti
    Faxalv, Lars
    Larsson, Pia
    Lindahl, Tomas L.
    Boknas, Niklas
    PLATELETS, 2023, 34 (01)
  • [24] Republished Education in Heart: New P2Y12 inhibitors
    Storey, Robert F.
    POSTGRADUATE MEDICAL JOURNAL, 2012, 88 (1035) : 49 - 54
  • [25] Elderly patients are hyperresponsive to potent P2Y12 inhibitors
    Mutschlechner, D.
    Tscharre, M.
    Wadowski, P.
    Lee, S.
    Pultar, J.
    Weikert, C.
    Panzer, S.
    Gremmel, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Trends in Spending for P2Y12 Inhibitors by Medicare and Medicaid
    Essa, Mohammed
    Ross, Joseph S.
    Dhruva, Sanket
    Desai, Nihar R.
    Yeh, Robert W.
    Faridi, Kamil
    CIRCULATION, 2022, 146
  • [27] P2Y12 Inhibitors in Cardiovascular Disease: Focus on Prasugrel
    Scott, Day Marice
    Norwood, Rhonda M.
    Parra, David
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (01) : 64 - 76
  • [28] P2Y12 inhibitors: do they increase cancer risk?
    Fierro, Joseph J.
    Cave, Brandon
    Khouzam, Rami N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [29] Comparison of the Efficacy and Safety Profiles of Different P2Y12 Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction in the COVID-19 Era
    Kavya, Ali N.
    Sahin, Mursel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [30] Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial
    Berger, Jeffrey S.
    Neal, Matthew D.
    Kornblith, Lucy Z.
    Gong, Michelle N.
    Reynolds, Harmony R.
    Cushman, Mary
    Althouse, Andrew D.
    Lawler, Patrick R.
    McVerry, Bryan J.
    Kim, Keri S.
    Baumann Kreuziger, Lisa
    Solomon, Scott D.
    Kosiborod, Mikhail N.
    Berry, Scott M.
    Bochicchio, Grant V.
    Contoli, Marco
    Farkouh, Michael E.
    Froess, Joshua D.
    Gandotra, Sheetal
    Greenstein, Yonatan
    Hade, Erinn M.
    Hanna, Nicholas
    Hudock, Kristin
    Hyzy, Robert C.
    Ibanez Estellez, Fatima
    Iovine, Nicole
    Khanna, Ashish K.
    Khatri, Pooja
    Kirwan, Bridget-Anne
    Kutcher, Matthew E.
    Leifer, Eric
    Lim, George
    Lopes, Renato D.
    Lopez-Sendon, Jose L.
    Luther, James F.
    Nigro Maia, Lilia
    Quigley, John G.
    Wahid, Lana
    Wilson, Jennifer G.
    Zarychanski, Ryan
    Kindzelski, Andrei
    Geraci, Mark W.
    Hochman, Judith S.
    JAMA NETWORK OPEN, 2023, 6 (05) : E2314428
12345